Digital Therapeutics

Global Market Trajectory & Analytics

MCP11567

EXECUTIVE ENGAGEMENTS

OUTREACH

6337
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1014
Interactions with Platform & by Email

PARTICIPANTS

192
Unique # Participated

VALIDATIONS

41
Responses Validated*

COMPETITORS

56
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

60

PAGES

205

EDITION

7

PRICE

USD 4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Digital Therapeutics estimated at US$347.2 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 24.6% over the period 2020-2027.Preventive, one of the segments analyzed in the report, is projected to grow at a 22.7% CAGR to reach US$421.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Treatment/Care segment is readjusted to a revised 25.3% CAGR for the next 7-year period. This segment currently accounts for a 71% share of the global Digital Therapeutics market.
The Digital Therapeutics market in the U.S. is estimated at US$103.8 Million in the year 2020. The country currently accounts for a 29.9% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$282.8 Million in the year 2027 trailing a CAGR of 24.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 21.6% and 21.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 17.5% CAGR while Rest of European market (as defined in the study) will reach US$282.8 Million by the year 2027.

SELECT PLAYERS

Canary Health, Inc.; Dthera Sciences; Fitbit Health Solutions; Livongo Health, Inc.; Medtronic, Plc; Omada Health, Inc.; Propeller Health; Pear Therapeutics, Inc.; Proteus Digital Health, Inc.; WellDoc, Inc.

SEGMENTS

» Application (Preventive, Treatment/Care) » Sales Channel (B2C, B2B)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
Digital Therapeutics: An Introduction
Outlook
Leading Markets
Factors Impeding Growth
2. FOCUS ON SELECT PLAYERS
Canary Health, Inc. (USA)
Dthera Sciences (USA)
Fitbit Health Solutions (USA
Livongo Health, Inc. (USA)
Medtronic, Plc (Ireland)
Omada Health, Inc. (USA)
Propeller Health (USA)
Pear Therapeutics, Inc. (USA)
Proteus Digital Health, Inc. (USA)
WellDoc, Inc. (USA)
3. MARKET TRENDS & DRIVERS
Digital Therapeutics Continue to Attract Venture Capital Investments
TABLE: Total Venture Capital Funding and Number of Deals in Digital Health Space: 2011-2018
TABLE: Digital Health Funding by Segment (in US$ Million): 9M 2019
Startups Flock the Digital Therapeutics Market
Select Digital Therapeutics Startups
Digital Health Unicorn Startups
Table: Quarterly Investments by Digital Therapeutics Startups in US$ Million: Q1 2018 to Q2 2019
Pipeline Products Drive Growth Prospects
A Snapshot of Select DTx Pipeline Products
Pharma Majors Foray into Uncharted Territory
Pharmaceutical Companies Team Up with Payers to Seek Reimbursement
Growing Focus on Preventative Healthcare Widens Growth Opportunities
Overcoming the Stigma of Mental Health through Digital Therapeutics
Global Number of People Suffering from Mental Disorders (In Million)
Growing Prevalence of Chronic Diseases to Boost Market Growth
TABLE: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
TABLE: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
Digital Therpeutics in Oncology
Proliferation of Smart Devices Bodes Well for Market Growth
TABLE: Smartphone Penetration (as a Proportion of Total Mobile Users) by Region for the Years 2018 and 2025
TABLE: United States Mobile Health Apps Market by Type (in %): 2018 & 2025
Growing Focus on Reducing Healthcare Costs Bolsters Market Growth
TABLE: Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022
Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver
TABLE: Global Population for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Treatment/Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Treatment/Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
USA Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Canada Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Japan Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
China Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
France Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Germany Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Italy Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
UK Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
Rest of World Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
Total Companies Profiled: 56

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com